Newsletter | October 13, 2026

10.13.26 -- Assess Biomolecular Stability With Confidence

Using DSC To Optimize Antibody Drug Conjugates

Drug load can influence the thermal behavior of a formulation, creating measurable changes that may help distinguish one concentration from another. See how a DSC thermogram was able to detect and quantify the differences in varying drug loads with respect to thermal parameters.

 

Determining Thermal Stability Of Antibodies With A Nano DSC

In a DSC scan, an unfolding event appears as an endothermic peak. The shape of the peak in the thermogram provides further insight into the properties of the sample. Examine an instrument with data analysis software capabilities that easily deconvolutes thermograms.

 

Characterizing Protein Stability By DSC

Protein stability depends on a complex balance of thermodynamic forces that shape how proteins fold, unfold, and respond to changing conditions. Discover how DSC quantifies thermodynamic forces, providing valuable insight for protein engineering and therapeutic formulation.

 

Life Science Applications Of Differential Scanning Calorimetry (DSC)

Protein stability can shape everything from candidate selection to formulation and optimization. Learn how DSC directly measures macromolecular stability, unfolding, and binding interactions, providing valuable thermodynamic insights for protein engineering.

 

VIDEO FEATURE

Assess Biomolecular Stability With Confidence

Gain deeper insight into biomolecular stability with highly sensitive thermal analysis. Thermodynamic measurements help evaluate formulation performance, detect structural changes, and more.

 

SOLUTIONS

 

Reliable Solutions For Next-Gen Biotherapeutic Development

 

Waters Corporation provides a comprehensive portfolio of trusted solutions that help biopharmaceutical companies ensure product quality, safety, and efficacy throughout development and manufacturing. 

 

Our Microcalorimetry, Thermal Analysis, and Rheology technologies measure critical quality attributes across a wide range of biotherapeutics, including monoclonal antibodies, cell and gene therapies, and vaccines. Unlike small-molecule drugs, biotherapeutics are inherently complex and heterogeneous, requiring rigorous characterization and quality control at every stage of development. 

 

Explore our solutions to see how they support biotherapeutic development, from early research through commercial manufacturing.